VRDN Annual FCF
-$185.07 M
-$90.43 M-95.56%
31 December 2023
Summary:
As of January 23, 2025, VRDN annual free cash flow is -$185.07 million, with the most recent change of -$90.43 million (-95.56%) on December 31, 2023. During the last 3 years, it has fallen by -$155.25 million (-520.60%). VRDN annual FCF is now -15677.32% below its all-time high of -$1.17 million, reached on December 31, 2013.VRDN Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VRDN Quarterly FCF
-$68.00 M
-$21.84 M-47.31%
30 September 2024
Summary:
As of January 23, 2025, VRDN quarterly free cash flow is -$68.00 million, with the most recent change of -$21.84 million (-47.31%) on September 30, 2024. Over the past year, it has dropped by -$28.61 million (-72.64%). VRDN quarterly FCF is now -80098.82% below its all-time high of $85.00 thousand, reached on March 31, 2014.VRDN Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VRDN TTM FCF
-$197.43 M
-$28.61 M-16.95%
30 September 2024
Summary:
As of January 23, 2025, VRDN TTM free cash flow is -$197.43 million, with the most recent change of -$28.61 million (-16.95%) on September 30, 2024. Over the past year, it has dropped by -$16.14 million (-8.90%). VRDN TTM FCF is now -53593.77% below its all-time high of -$367.70 thousand, reached on March 31, 2013.VRDN TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VRDN Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -95.6% | -72.6% | -8.9% |
| 3 y3 years | -520.6% | -72.6% | -8.9% |
| 5 y5 years | -578.2% | -72.6% | -8.9% |
VRDN Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -237.0% | at low | -309.2% | at low | -259.5% | at low |
| 5 y | 5-year | -520.6% | at low | -1220.9% | at low | -600.1% | at low |
| alltime | all time | <-9999.0% | at low | <-9999.0% | at low | <-9999.0% | at low |
Viridian Therapeutics Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$68.00 M(+47.3%) | -$197.43 M(+16.9%) |
| June 2024 | - | -$46.16 M(+2.1%) | -$168.82 M(+0.4%) |
| Mar 2024 | - | -$45.22 M(+18.9%) | -$168.20 M(-9.1%) |
| Dec 2023 | -$185.07 M(+95.6%) | -$38.05 M(-3.4%) | -$185.07 M(+2.1%) |
| Sept 2023 | - | -$39.39 M(-13.5%) | -$181.29 M(+11.4%) |
| June 2023 | - | -$45.55 M(-26.6%) | -$162.67 M(+20.0%) |
| Mar 2023 | - | -$62.09 M(+81.2%) | -$135.50 M(+43.2%) |
| Dec 2022 | -$94.64 M(+72.3%) | -$34.27 M(+65.1%) | -$94.64 M(+22.9%) |
| Sept 2022 | - | -$20.76 M(+13.0%) | -$76.98 M(+12.7%) |
| June 2022 | - | -$18.38 M(-13.4%) | -$68.28 M(+5.7%) |
| Mar 2022 | - | -$21.22 M(+27.7%) | -$64.59 M(+17.6%) |
| Dec 2021 | -$54.92 M(+84.2%) | -$16.62 M(+37.8%) | -$54.92 M(+15.1%) |
| Sept 2021 | - | -$12.06 M(-17.9%) | -$47.73 M(+16.9%) |
| June 2021 | - | -$14.69 M(+27.1%) | -$40.81 M(+24.0%) |
| Mar 2021 | - | -$11.55 M(+22.6%) | -$32.92 M(+10.4%) |
| Dec 2020 | -$29.82 M(-17.5%) | -$9.43 M(+83.1%) | -$29.82 M(+5.7%) |
| Sept 2020 | - | -$5.15 M(-24.2%) | -$28.20 M(-12.8%) |
| June 2020 | - | -$6.79 M(-19.7%) | -$32.34 M(-1.3%) |
| Mar 2020 | - | -$8.46 M(+8.4%) | -$32.75 M(-9.4%) |
| Dec 2019 | -$36.14 M(+32.4%) | -$7.81 M(-15.9%) | -$36.14 M(-1.1%) |
| Sept 2019 | - | -$9.28 M(+28.8%) | -$36.56 M(+6.6%) |
| June 2019 | - | -$7.21 M(-39.2%) | -$34.28 M(+8.2%) |
| Mar 2019 | - | -$11.85 M(+44.0%) | -$31.68 M(+16.1%) |
| Dec 2018 | -$27.29 M | -$8.23 M(+17.4%) | -$27.29 M(+3.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2018 | - | -$7.01 M(+52.3%) | -$26.34 M(+5.1%) |
| June 2018 | - | -$4.60 M(-38.3%) | -$25.06 M(-9.3%) |
| Mar 2018 | - | -$7.46 M(+2.5%) | -$27.64 M(-2.7%) |
| Dec 2017 | -$28.41 M(+292.8%) | -$7.28 M(+27.1%) | -$28.41 M(+23.5%) |
| Sept 2017 | - | -$5.73 M(-20.3%) | -$23.01 M(+25.0%) |
| June 2017 | - | -$7.18 M(-12.7%) | -$18.41 M(+39.1%) |
| Mar 2017 | - | -$8.23 M(+338.3%) | -$13.24 M(+83.0%) |
| Dec 2016 | -$7.23 M(+3.0%) | -$1.88 M(+67.0%) | -$7.23 M(+8.3%) |
| Sept 2016 | - | -$1.12 M(-44.0%) | -$6.68 M(-15.4%) |
| June 2016 | - | -$2.01 M(-9.8%) | -$7.89 M(-2.5%) |
| Mar 2016 | - | -$2.23 M(+68.3%) | -$8.09 M(+15.3%) |
| Dec 2015 | -$7.02 M(+183.2%) | -$1.32 M(-43.4%) | -$7.02 M(+0.9%) |
| Sept 2015 | - | -$2.34 M(+5.7%) | -$6.96 M(+27.6%) |
| June 2015 | - | -$2.21 M(+91.7%) | -$5.45 M(+46.7%) |
| Mar 2015 | - | -$1.15 M(-8.4%) | -$3.72 M(+49.9%) |
| Dec 2014 | -$2.48 M(+111.3%) | -$1.26 M(+51.5%) | -$2.48 M(+56.8%) |
| Sept 2014 | - | -$831.00 K(+75.3%) | -$1.58 M(+50.8%) |
| June 2014 | - | -$474.00 K(-657.6%) | -$1.05 M(+45.5%) |
| Mar 2014 | - | $85.00 K(-123.6%) | -$720.30 K(-38.6%) |
| Dec 2013 | -$1.17 M(-81.5%) | -$360.60 K(+20.9%) | -$1.17 M(+44.4%) |
| Sept 2013 | - | -$298.30 K(+103.8%) | -$812.40 K(+58.0%) |
| June 2013 | - | -$146.40 K(-60.2%) | -$514.10 K(+39.8%) |
| Mar 2013 | - | -$367.70 K | -$367.70 K |
| Dec 2012 | -$6.33 M | - | - |
FAQ
- What is Viridian Therapeutics annual free cash flow?
- What is the all time high annual FCF for Viridian Therapeutics?
- What is Viridian Therapeutics annual FCF year-on-year change?
- What is Viridian Therapeutics quarterly free cash flow?
- What is the all time high quarterly FCF for Viridian Therapeutics?
- What is Viridian Therapeutics quarterly FCF year-on-year change?
- What is Viridian Therapeutics TTM free cash flow?
- What is the all time high TTM FCF for Viridian Therapeutics?
- What is Viridian Therapeutics TTM FCF year-on-year change?
What is Viridian Therapeutics annual free cash flow?
The current annual FCF of VRDN is -$185.07 M
What is the all time high annual FCF for Viridian Therapeutics?
Viridian Therapeutics all-time high annual free cash flow is -$1.17 M
What is Viridian Therapeutics annual FCF year-on-year change?
Over the past year, VRDN annual free cash flow has changed by -$90.43 M (-95.56%)
What is Viridian Therapeutics quarterly free cash flow?
The current quarterly FCF of VRDN is -$68.00 M
What is the all time high quarterly FCF for Viridian Therapeutics?
Viridian Therapeutics all-time high quarterly free cash flow is $85.00 K
What is Viridian Therapeutics quarterly FCF year-on-year change?
Over the past year, VRDN quarterly free cash flow has changed by -$28.61 M (-72.64%)
What is Viridian Therapeutics TTM free cash flow?
The current TTM FCF of VRDN is -$197.43 M
What is the all time high TTM FCF for Viridian Therapeutics?
Viridian Therapeutics all-time high TTM free cash flow is -$367.70 K
What is Viridian Therapeutics TTM FCF year-on-year change?
Over the past year, VRDN TTM free cash flow has changed by -$16.14 M (-8.90%)